Compare BVS & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | GMRE |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 438.8M |
| IPO Year | 2021 | N/A |
| Metric | BVS | GMRE |
|---|---|---|
| Price | $7.40 | $33.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $13.50 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 277.3K | 130.8K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 8.97% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $563,829,000.00 | $144,829,000.00 |
| Revenue This Year | N/A | $7.49 |
| Revenue Next Year | $7.11 | $3.18 |
| P/E Ratio | $48.57 | ★ N/A |
| Revenue Growth | 1.58 | ★ 6.04 |
| 52 Week Low | $5.81 | $29.05 |
| 52 Week High | $11.25 | $45.75 |
| Indicator | BVS | GMRE |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 49.22 |
| Support Level | $7.26 | $32.90 |
| Resistance Level | $7.71 | $34.83 |
| Average True Range (ATR) | 0.26 | 0.70 |
| MACD | -0.02 | -0.29 |
| Stochastic Oscillator | 44.75 | 30.17 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.